← Back to Search

GLS-5310 Vaccine for COVID-19

Phase 1
Waitlist Available
Research Sponsored by GeneOne Life Science, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 48 weeks post vaccination
Awards & highlights

Study Summary

This trial is testing a new vaccine to see if it is safe and effective in people who have already been vaccinated against Covid-19.

Eligible Conditions
  • COVID-19
  • Coronavirus
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 48 weeks post vaccination
This trial's timeline: 3 weeks for screening, Varies for treatment, and through 48 weeks post vaccination for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine antibody responses after a single dose of vaccine
Incidence of adverse events
Secondary outcome measures
Evaluation of neutralizing antibody response induced by GLS-5310 relative to treatment arm
Evaluation of positive response rate of T cell responses induced by GLS-5310 DNA vaccine

Trial Design

4Treatment groups
Experimental Treatment
Group I: GLS-5310 ID + GeneDerm 80 kPa, 30 secondsExperimental Treatment1 Intervention
GLS-5310 ID + GeneDerm administered at Visit 1
Group II: GLS-5310 ID + GeneDerm 65 kPa, 30 seconds + GLS-5310 INExperimental Treatment1 Intervention
GLS-5310 ID + GeneDerm + GLS-5310 IN administered at Visit 1
Group III: GLS-5310 ID + GeneDerm 65 kPa, 30 secondsExperimental Treatment1 Intervention
GLS-5310 ID + GeneDerm administered at Visit 1
Group IV: GLS-5310 ID + GeneDerm 65 kPa, 15 secondsExperimental Treatment1 Intervention
GLS-5310 ID + GeneDerm administered at Visit 1

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

GeneOne Life Science, Inc.Lead Sponsor
15 Previous Clinical Trials
1,371 Total Patients Enrolled
4 Trials studying COVID-19
529 Patients Enrolled for COVID-19
~23 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top